Skip to main content

Danaher Corporation guidance

  • DHR · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$229.91−1.33%Close 16 Nov 2026 · Market value $159.0B

Danaher Corporation gives no forecast in figures in its latest earnings release (21 Oct 2026). Many companies give their outlook on the call only, or none at all.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Guidance against results last two years

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
Organic revenue growthFY2026+3% to +4%Lowered once—To come

DHR in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.